X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-29 | RLMD | Traversa Sergio | CEO | P - Purchase | $3.87 | +100,000 | 244,024 | +69% | +$386,738 | |||||
| M | 2024-01-29 | RLMD | Shenouda Maged | CFO | P - Purchase | $3.85 | +32,675 | 34,903 | >999% | +$125,717 | |||||
| M | 2024-01-29 | RLMD | Ence Chuck | CA, CO | P - Purchase | $3.87 | +38,970 | 38,970 | New | +$150,920 | |||||
2023-05-23 | RLMD | O'Gorman Cedric | Chief Medical Officer | P - Purchase | $3.18 | +10,000 | 10,121 | >999% | +$31,800 | ||||||
2022-12-08 | RLMD | Traversa Sergio | CEO | P - Purchase | $2.10 | +55,250 | 144,024 | +62% | +$115,804 | ||||||
| DM | 2022-06-30 | RLMD | Traversa Sergio | CEO | S - Sale+OE | $18.80 | -29,767 | 88,774 | -25% | -$559,577 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |